Gergely, B.,
Vereb, M. A.,
Rebenku, I.,
Vereb, G.,
Szöőr, Á.:
Targeting HER2-Positive Solid Tumors with CAR NK Cells: CD44 Expression Is a Critical Modulator of HER2-Specific CAR NK Cell Efficacy.
Cancers. 17 (5), 1-17, (article identifier: 731), 2025.
Barden, M.,
Elsenbroich, P. R.,
Haas, V.,
Ertelt, M.,
Pervan, P.,
Velas, L.,
Gergely, B.,
Szöőr, Á.,
Harrer, D. C.,
Bezler, V.,
Holzinger, A.,
Friis, R. U. W.,
Vereb, G.,
Schütz, G.,
Schoeder, C. T.,
Hombach, A. A.,
Abken, H.:
Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.
J. Immunother. Cancer. 12 (12), 1-14, (article identifier: 010208), 2024.
